Examples of using
Nuspojava u djece
in Croatian and their translations into English
{-}
Colloquial
Ecclesiastic
Computer
Opis odabranih nuspojava u djece i adolescenata.
Description of selected adverse reactions in children and adolescents.
Kao što je slučaj i s drugim blokatorima RAAS-a,glavobolja je česta nuspojava u djece liječene aliskirenom.
As for other RAAS blockers,headache is a common adverse event in children treated with aliskiren.
Učestalost, narav i težina nuspojava u djece inače su jednake onima u odraslih.
The frequency nature and severity of adverse reactions in children are otherwise the same as in adults.
U dovršenim kliničkim ispitivanjima sa 71 prethodno liječenim pedijatrijskim bolesnikom, utvrđeno je dasu učestalost, vrsta i težina nuspojava u djece slične onima u odraslih.
In completed clinical studies with 71 paediatric previously treated patients, the frequency,type and severity of adverse reactions in children were found to be similar to those in adults.
Najčešće prijavljena nuspojava u djece bilo je povraćanje.
In children, the most commonly reported adverse reaction was vomiting.
Profil nuspojava u djece koja boluju od bronhalne astme bio je kvalitativno sličan onomu u inače zdrave djece..
The adverse reaction profile in children with pre-existing bronchial asthma was qualitatively similar to that of otherwise healthy children..
Učestalost, vrsta i težina nuspojava u djece bile su iste kao i u odraslih.
Frequency, type and severity of adverse reactions in children are the same as in adults.
Profil nuspojava u djece i adolescenata općenito je bio sličan onom zabilježenom u odraslih bolesnika, uz problem specifičan za pedijatrijsku populaciju koji se odnosi na zastoj u rastu.
In general, the adverse reactions profile in children and adolescents was similar to that observed in adults, although there is a paediatric-specific concern regarding growth inhibition.
Učestalost, vrsta i težina nuspojava u djece iste su kao u odraslih.
Infusion site Frequency, type and severity of adverse reactions in children are the same as in adults.
Na temelju ograničene količine podataka o sigurnosti dostupnih iz farmakokinetičkog ispitivanja liječenja aliskirenom u 39 hipertenzivne djece u dobi od 6-17 godina, očekuje se da će učestalost,vrsta i težina nuspojava u djece biti slična onima viđenim u hipertenzivnih odraslih osoba.
Based on the limited amount of safety data available from a pharmacokinetic study of aliskiren treatment in 39 hypertensive children 6-17 years of age, the frequency,type and severity of adverse reactions in children are expected to be similar to that seen in hypertensive adults.
Učestalost, vrsta i težina nuspojava u djece slične su onima zabilježenima u odraslih.
Frequency, type and severity of adverse reactions in children are similar to those reported in adults.
Očekuju se ista učestalost, tip i težina nuspojava u djece kao i u odraslih osoba.
Frequency, type and severity of adverse reactions in children are expected to be the same as in adults.
Najčešća nuspojava u djece je vrućica koja se pojavljuje u više od 1 na 10 bolesnika.
The most common side effect in children is fever and this occurs in more than 1 patient in 10.
Pretpostavlja se da su učestalost, vrsta i jačina nuspojava u djece jednaki kao u odraslih.
Frequency, type and severity of adverse reactions in children are assumed to be the same as in adults.
Učestalost, vrsta i težina nuspojava u djece bile su općenito slične onima viđenim u hipertenzivnih odraslih osoba.
The frequency, type and severity of adverse reactions in children were generally similar to those seen in hypertensive adults.
Očekuje se da će učestalost, vrsta i ozbiljnost nuspojava u djece biti jednaki kao u odraslih osoba.
Frequency, type and severity of adverse reactions in children are expected to be the same as in adults.
Ukupna incidencija nuspojava u djeceu dobi od 2 do 11 godina bila je slična u skupinama koje su uzimale desloratadin i onima koje su primale placebo.
The overall incidence of adverse events in children 2 through 11 years of age was similar for the desloratadine and the placebo groups.
Do slučajnog unos salicilata tijekom dojenja ne prati razvoj nuspojava u djece i ne zahtijeva zaustavljanje dojenje.
Accidental intake of salicylates during lactation is not accompanied by the development of adverse reactions in the child and does not require stopping breastfeeding.
Zbog mogućnosti nastupa ozbiljnih nuspojava u djece koja doje, treba odlučiti treba li prekinuti dojenje ili liječenje Extavijom.
Because of the potential for serious adverse reactions in nursing infants a decision should be made whether to discontinue breast- feeding or Extavia therapy.
Iako je ispitan ograničen broj djece,postoji sklonost većoj učestalosti nuspojava u djeceu dobi od 7 do 16 godina u usporedbi s odraslima.
Although a limited number of children have been studied,there is a tendency for higher frequencies of adverse reactions in children aged 7-16 years as compared to adults.
Učestalost, vrsta i težina nuspojava u djece bile su u biti slične onima u odraslih.
Frequency, type and severity of adverse reactions in children were essentially similar to those in adults.
Učestalost, vrsta i intenzitet nuspojava u djece slični su onima zabilježenima u odraslih.
Frequency, type and severity of adverse reactions in children are similar to those observed in adults.
U oba ispitivanja učestalost, vrsta i težina nuspojava primijećenih u djece i adolescenata u načelu su bile u skladu s onima primijećenim u odraslih bolesnika, uz iznimku infekcija koje su bile zabilježene uz veću učestalost, osobito kod djece mlađe od 3 godine.
In both studies, frequency, type and severity of adverse reactions observed in children and adolescents have been generally consistent with those observed in adults, with the exception of infections which were reported at a higher frequency, especially in children below the age of 3 years.
Zbog mogućnosti ozbiljnih nuspojava u dojene djece, za vrijeme liječenja lijekom Bortezomib Hospira potrebno je prekinuti dojenje.
Because of the potential for serious adverse reactions in breast-fed infants, breast-feeding should be discontinued during treatment with Bortezomib Hospira.
Uzrok nuspojava zabilježenih u djece koja primaju lijek Pedea teško je procijeniti jer one mogu biti povezane s otvorenim arterijskim duktusom ili samim lijekom Pedea.
The cause of any side effects seen in babies receiving Pedea is difficult to assess because they may be related to the patent ductus arteriosus or to Pedea itself.
Primijećena je veća učestalost ozbiljnih nuspojava u mlađe djece, u dobi 0-5 godina(92%) u odnosu na stariju djecu, u dobi 6-11 godina(80%) i 12-21 godina(67%), odnosno odrasle.
A higher frequency of serious adverse reactions in younger children aged 0-5 years(92%) has been observed compared to older children aged 6-11 and 12-21 years respectively(80% and 67%) and adults.
Kako bi se izbjegla ova u djece važna nuspojava, ljekari preferiraju najkraću moguću upotrebu kortikosteroida u najmanjim mogućim dozama.
To avoid this important side effect in children, doctors prefer to use corticosteroids for the shortest possible period and at the lowest dosage.
Hrvatski
Deutsch
Italiano
عربى
Български
বাংলা
Český
Dansk
Ελληνικά
Español
Suomi
Français
עִברִית
हिंदी
Magyar
Bahasa indonesia
日本語
Қазақ
한국어
മലയാളം
मराठी
Bahasa malay
Nederlands
Norsk
Polski
Português
Română
Русский
Slovenský
Slovenski
Српски
Svenska
தமிழ்
తెలుగు
ไทย
Tagalog
Turkce
Українська
اردو
Tiếng việt
中文